Uptake and metabolism of hydroxymatairesinol in relation to its anticarcinogenicity in DMBA-induced rat mammary carcinoma model.

Saarinen, N M; Huovinen, R; Wärri, A; Mäkelä, S I; Valentín-Blasini, L; Needham, L; Eckerman, C; Collan, Y U; Santti, R

Saarinen, N M; Huovinen, R; Wärri, A; Mäkelä, S I; Valentín-Blasini, L; Needham, L; Eckerman, C; Collan, Y U; Santti, R.

Affiliation

Saarinen NM; Department of Anatomy, Institute of Biomedicine, University of Turku, FIN-20520 Turku, Finland.

Nutr Cancer ; 41(1-2): 82-90, 2001.

Article in En | MEDLINE | ID: mdl-12094633

Subject(s)

4-Butyrolactone/analogs & derivatives; 9,10-Dimethyl-1,2-benzanthracene; Anticarcinogenic Agents/pharmacokinetics; Anticarcinogenic Agents/therapeutic use; Isoflavones; Lignans/pharmacokinetics; Lignans/therapeutic use; Mammary Neoplasms, Experimental/prevention & control; 4-Butyrolactone/blood; 4-Butyrolactone/urine; Adenocarcinoma/chemically induced; Adenocarcinoma/pathology; Adenocarcinoma/prevention & control; Animals; Diet; Estrogens, Non-Steroidal/blood; Estrogens, Non-Steroidal/urine; Female; Lignans/administration & dosage; Lignans/blood; Lignans/urine; Mammary Neoplasms, Experimental/chemically induced; Mammary Neoplasms, Experimental/pathology; Organ Size; Phytoestrogens; Plant Preparations; Rats; Rats, Sprague-Dawley; Uterus/pathology

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: 4-Butyrolactone / Anticarcinogenic Agents / Lignans / 9,10-Dimethyl-1,2-benzanthracene / Isoflavones / Mammary Neoplasms, Experimental Limits: Animals Language: En Journal: Nutr Cancer Year: 2001 Document type: Article Affiliation country: Finland

Search on Google

Add to My VHL

XML

PubMed Links